Skip to main content

Advertisement

Log in

Expression Analysis of Survivin and XIAP in Gallbladder Cancer: a Case-control Study in Indo-Gangetic Plain

  • Original Research
  • Published:
Journal of Gastrointestinal Cancer Aims and scope Submit manuscript

Abstract

Purpose

Gallbladder cancer is a highly mortal disease with poor prognosis because of late presentation of disease. Survivin and X-linked inhibitor of apoptosis (XIAP) are one of the two important members of inhibitors of apoptosis. Thus, this study aimed to look at the expression of Survivin and XIAP in gallbladder cancer patients.

Methods

Survivin and XIAP expression were investigated in tissues of gallbladder cancer patients (40 cases) and compared with cholelithiasis as control (40 cases) by using immunohistochemistry. Their expression was correlated with clinicopathological parameters.

Results

Significantly higher (p < 0.05), Survivin protein was expressed in gallbladder cancer (n = 67.5%) than control (n = 35%). But it did not show any significant association with any of the clinicopathological parameter while XIAP was not expressed in the GBC patients (p > 0.05).

Conclusion

Overexpression of Survivin in gallbladder cancer suggests its possible role and association with poor prognosis. But XIAP has not been found to be associated with gallbladder carcinogenesis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Hueman M, Vollmer C, Pawlik T. Evolving treatment strategies for gallbladder cancer. Ann Surg Oncol. 2009;16:2101–5. https://doi.org/10.1245/s10434-009-0538-x.

    Article  PubMed  Google Scholar 

  2. Cobourn N, Cleary S, Tan J, Law CH. Surgery for gallbladder cancer: a population-based analysis. J Am Coll Surg. 2008;207:371–82.

    Article  Google Scholar 

  3. Boutros C, Gary M, Baldwin K, Somasundar P. Gallbladder cancer: past, present and an uncertain future. Surg Oncol. 2012;21(4):e183–91.

    Article  CAS  Google Scholar 

  4. Dixit R, Shukla VK, Pandey M. Molecular alterations in gallbladder cancer. World J Pathol. 2012;1:31–4.

    Google Scholar 

  5. Qiu Y, Li X, Yi B, et al. Protein phosphatase PHLPP induces cell apoptosis and exerts anticancer activity by inhibiting Survivin phosphorylation and nuclear export in gallbladder cancer. Oncotarget. 2015;6(22):19148–62.

    Article  Google Scholar 

  6. Henry LR, Lee HO, Lee JS, et al. Clinical implications of fibroblast activation protein in patients with colon cancer. Clin Cancer Res. 2007;13(6):1736–41.

    Article  CAS  Google Scholar 

  7. Yang YL, Li XM. The IAP family: endogenous caspase inhibitors with multiple biological activities. Cell Res. 2000;10(3):169–77.

    Article  CAS  Google Scholar 

  8. Ngan CY, Yamamoto H, Seshimo I, et al. Quantitative evaluation of vimentin expression in tumour stroma of colorectal cancer. Br J Cancer. 2007;96(6):986–92.

    Article  CAS  Google Scholar 

  9. Zhu L, Cheng X, Ding Y, et al. Bone marrow-derived myofibroblasts promote colon tumorigenesis through the IL-6/JAK2/STAT3 pathway. Cancer Lett. 2014;343(1):80–9.

    Article  CAS  Google Scholar 

  10. LeBleu VS, Taduri G, O’Connell J, et al. Origin and function of myofibroblasts in kidney fibrosis. Nat Med. 2013;19(8):1047–53.

    Article  CAS  Google Scholar 

  11. Tu SP, Chi AL, Ai W, et al. p53 inhibition of AP1-dependent TFF2 expression induces apoptosis and inhibits cell migration in gastric cancer cells. Am J Physiol Gastrointest Liver Physiol. 2009;297(2):G385–96.

    Article  CAS  Google Scholar 

  12. Kashkar H. X-linked inhibitor of apoptosis: a chemoresistance factor or a hollow promise. Clin Cancer Res. 2010;16:4496–502.

    Article  CAS  Google Scholar 

  13. Srinivasula SM, Ashwell JD. IAPs: what’s in a name? Mol Cell. 2008;30:123–35.

    Article  CAS  Google Scholar 

  14. Tamm I, Kornblau SM, Segall H, et al. Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias. Clin Cancer Res. 2000;6:1796–803.

    CAS  PubMed  Google Scholar 

  15. Liu SS, Tsang BK, Cheung AN, et al. Anti-apoptotic proteins, apoptotic and proliferative parameters and their prognostic significance in cervical carcinoma. Eur J Cancer. 2001;37:1104–10.

    Article  CAS  Google Scholar 

  16. Krajewska M, Kim H, Kim C, et al. Analysis of apoptosis protein expression in early-stage colorectal cancer suggests opportunities for new prognostic biomarkers. Clin Cancer Res. 2005;11:5451–61.

    Article  CAS  Google Scholar 

  17. Ryan BM, Konecny GE, Kahlert S, et al. Survivin expression in breast cancer predicts clinical outcome and is associated with HER2, VEGF, urokinase plasminogen activator and PAI-1. Ann Oncol. 2006;17:597–604.

    Article  CAS  Google Scholar 

  18. Jha K, Shukla M, Pandey M. Survivin expression and targeting in breast cancer. Surg Oncol. 2012a;21:125–31.

    Article  Google Scholar 

  19. Meijer L, Jézéquel A, Roberge M. Survivin in apoptosis control and cell cycle regulation in cancer. Prog Cell Cycle Res. 2003;5:447–52.

    Google Scholar 

  20. Zhou S, Ye W, Shao Q, Qi Y, Zhang M, Liang J. Prognostic significance of XIAP and NF-κB expression in esophageal carcinoma with postoperative radiotherapy. World J Surg Oncol. 2013;11:288.

    Article  Google Scholar 

  21. Qin S, Xu C, Li S, et al. Hyperthermia induces apoptosis by targeting Survivin in esophageal cancer. Oncol Rep. 2015;34(5):2656–64.

    Article  CAS  Google Scholar 

  22. Wei D, Qi Z, Wei-wen L, Yun-le W. Expression of laminin and survivin in primary gallbladder carcinoma. Chin J Pathophysiol. 2006;22(11):2207–11. (Abstract)

    Google Scholar 

  23. Tanaka M, Chijiiwa K. Carcinoma of the gallbladder: an appraisal of surgical resection. Surgery. 1994;115:751–6.

    PubMed  Google Scholar 

  24. Kennedy SM, O’Driscoll L, Purcell R, et al. Prognostic importance of survivin in breast cancer. Br J Cancer. 2003;88:1077–83.

    Article  CAS  Google Scholar 

  25. Al-Joudi FS, Iskandar ZA, Hasnan J, et al. Expression of survivin and its clinicopathological correlations in invasive ductal carcinoma of the breast. Singap Med J. 2007;48(7):607.

    CAS  Google Scholar 

  26. Jha K, Kumar M, Shukla VK, Pandey M. Survivin expression and correlation with clinico-pathological parameters in breast cancer. World J Pathol. 2012b;1:23–30.

    Google Scholar 

  27. Augello C, Caruso L, Maggioni M, et al. Inhibitors of apoptosis proteins (IAPs) expression and their prognostic significance in hepatocellular carcinoma. BMC Cancer. 2009;9:125.

    Article  Google Scholar 

  28. Yie SM, Luo B, Ye NY, Xie K, Ye SR. Detection of Survivin-expressing circulating cancer cells in the peripheral blood of breast cancer patients by a RT-PCR ELISA. Clin Exp Metastasis. 2006;23:279–89.

    Article  CAS  Google Scholar 

  29. Khan S, Aspe JR, Asumen MG, et al. Extracellular, cell-permeable survivin inhibits apoptosis while promoting proliferative and metastatic potential. Br J Cancer. 2009;100:1073–86.

    Article  CAS  Google Scholar 

  30. Nigam J, Chandra A, Kazmi HR, et al. Expression of survivin mRNA in gallbladder cancer: a diagnostic and prognostic marker? Tumor Biol. 2014;35:9241–6.

    Article  CAS  Google Scholar 

  31. Won HS, Lee MA, Chung ES, et al. Comparison of thymidine phosphorylase expression and prognostic factors in gallbladder and bile duct cancer. BMC Cancer. 2010;10:564.

    Article  Google Scholar 

  32. Yim JH, Yoon JH, Kim SA, et al. Expression of X-linked inhibitor of apoptosis protein in neoplastic thyroid disorder. J Korean Med Sci. 2011;26:1191–5. https://doi.org/10.3346/jkms.2011.26.9.1191.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Mehrotra S, Languino LR, Raskett CM, Mercurio AM, Dohi T, Altieri DC. IAP regulation of metastasis. Cancer Cell. 2010;17:53–64. https://doi.org/10.1016/j.ccr.2009.11.021.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Chen X, Wang T, Yang D, et al. Expression of the IAP protein family acts cooperatively to predict prognosis in human bladder cancer patients. Oncol Lett. 2013;5:1278–84.

    Article  CAS  Google Scholar 

  35. Rodríguez-Berriguete G, Fraile B, de Bethencourt FR, et al. Role of IAPs in prostate cancer progression: immunohistochemical study in normal and pathological (benign hyperplastic, prostatic intraepithelial neoplasia and cancer) human prostate. BMC Cancer. 2010;10:18. https://doi.org/10.1186/1471-2407-10-18.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

Departmental research grant for financial support.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to V. K. Shukla.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Ethical Approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee.

Informed Consent

Informed consent was obtained from all individual participants included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dixit, R., Raza, M., Kumar, M. et al. Expression Analysis of Survivin and XIAP in Gallbladder Cancer: a Case-control Study in Indo-Gangetic Plain. J Gastrointest Canc 49, 487–492 (2018). https://doi.org/10.1007/s12029-017-0008-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12029-017-0008-9

Keywords

Navigation